RxDoctor Payments Data

Timothy Strigenz, MD

Pain Medicine · Bozeman, MTNPI 1801991682

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by Medtronic at 51.3% of the total. Reporting peaked in 2024 at $3,404 and has fallen 71.0% since, to $988 in 2025.

$10,050in general payments, 2019–2025

Across 150 payments — averaging $67.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Boston Scientific$2K
  • Vertos Medical, Inc.$635
  • Abbott$585
  • Nevro Corp.$517
  • Saluda Medical Americas, Inc.$317
  • plus $655 from 11 others

What the payments were for

  • Travel & lodging$4,90949%
  • Food & beverage$5,14151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pain medicine providers in Montanato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$292,356
Medicare patients
375
Services billed
10,577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib46$795
Gabapentin70$573
Pregabalin46$418
Duloxetine Hcl45$343
Meloxicam38$203
Oxycodone Hcl15$182
Methylprednisolone21$176
Methocarbamol13$115
Tramadol Hcl21$52
Cephalexin12$21
Diazepam18$13

Paid to pharmacies, not to this prescriber.

Other pain medicine in Bozeman

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →